Germany's doctors now prescribe digital apps for cognitive rehabilitation

Germany's healthcare system is embracing digital solutions for cognitive impairments. Doctors can now prescribe certified online programs, known as Digital Health Applications (DiGA), to patients with conditions like memory loss or attention deficits. These apps are fully covered by health insurers, marking a shift toward evidence-based digital therapies alongside traditional treatments.

By the end of 2023, however, no DiGA specifically for cognitive impairments had received official approval from the Federal Institute for Drugs and Medical Devices (BfArM).

The move comes as Germany faces an ageing population and growing demand for cognitive rehabilitation. Unlike generic brain-training apps, DiGA-certified programs—such as NeuroNation MED—have undergone clinical trials proving their effectiveness. Patients, including those recovering from post-COVID cognitive deficits, can now access these tools through a doctor's prescription.

The first 90 days of use are free, ensuring immediate support for those in need. A key advantage is personalisation: the apps adjust exercise difficulty based on individual cognitive abilities. This tailored approach helps bridge gaps when traditional therapy slots are limited.

Looking ahead, artificial intelligence and digital assessment tools could make these programs even more precise. The broader trend reflects Germany's push toward preventive care, blending digital innovation with established medical treatments. While no DiGA for cognitive impairments had been approved by late 2023, the system is evolving to integrate more evidence-based digital therapies.

Patients with cognitive challenges now have access to clinically validated digital tools at no initial cost. The integration of DiGA into Germany's healthcare system aims to improve outcomes through personalised, technology-driven therapies. As approvals expand, these programs may become a standard part of cognitive rehabilitation.